logo

Accucaps Industries, Manufacturing Capacity – Canada

One of 10,000+ projects Taiyo tracks in Canada.

Source: Pharmaceutical Technology

Project
Closed

Accucaps Industries is a contract manufacturer for the soft gelatine encapsulation of pharmaceutical and nutritional compounds based in North America. The company has been in operation since 1989. 2008 2008 Conversion of facility Strathroy, Ontario n/a 2008 (part of a global realignment) Accucaps Industries Ltd Ramar Contractors, Star Building Systems Accucaps Industries Ltd Accucaps Industries is

Status
Closed
Sector
Chemical (Industrial), Commercial, Government, Manufacturing (Industrial), Metal, Oil and Gas, Warehouse
Location
Canada
Updated
22 Jul 2026
Source
Pharmaceutical Technology

ConstructChat

Ask ConstructChat about Accucaps Industries, Manufacturing Capacity – Canada

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Accucaps Industries, Manufacturing Capacity – Canada” is an infrastructure initiative in the Chemical (Industrial) sector, located in Canada. Taiyo aggregates data on it from Pharmaceutical Technology.

Participants

Company

Status

Original status

closed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Accucaps Industries is a contract manufacturer for the soft gelatine encapsulation of pharmaceutical and nutritional compounds based in North America. The company has been in operation since 1989. 2008 2008 Conversion of facility Strathroy, Ontario n/a 2008 (part of a global realignment) Accucaps Industries Ltd Ramar Contractors, Star Building Systems Accucaps Industries Ltd Accucaps Industries is a contract manufacturer for the soft gelatine encapsulation of pharmaceutical and nutritional compounds based in North America. The company has been in operation since 1989. In April 2008 the Accucaps’ facility in Strathroy began a project to double production capacity and convert from mixed production to focus specifically on health and nutritional (H&N) products. This strategy is based on government announcements on stronger legislation for food and health products and will allow the company to provide better-quality production, at a potentially lower price, and with shorter lead times. The company has two operations in Canada, at Strathroy and Windsor. Both of these are registered with the US Food and Drug Administration (FDA) and Health Canada. These two operations together make Accucaps the largest soft gel contract manufacturer for the healthcare market in North America. The company provides a full range of services, including new product development, raw material sourcing, compounding and preparation, engineering of custom die shapes and sizes, and high-volume production using custom rotary soft gel machines. Preparations include minerals, oils, herbal products, and vitamins. This current good manufacturing practices (cGMP) facility is equipped with isolated bays for imprinting, packing, precision blending of liquid, semi-solids, suspensions, or emulsions, as well as custom encapsulation for different shapes, sizes, and colours. The Strathroy facility handles mixing batch sizes from 100kg to 2,000kg and can work with Polyethylene glycol (PEG), oil, wax, or silicone using gelatine sourced from porcine skin, bovine bone, or fish stock. Capsules can be manufactured in any number of colours with translucent, opaque or two-tone finishes. Capsules can also be printed on with logos or text if required. The Strathroy facility in Southwest Ontario is now converted for single use and is expected to become a centre of excellence for the production of health, nutritionals, and cosmetics in North America. Since its 2006 global expansion, Accucaps has also been active in the European market. The converted 125,000ft² facility is good manufacturing process (GMP) compliant and HHPD licensed and has product compounding facilities. It also contains 18 encapsulation machines capable of producing 4 billion doses per year (around 40 million capsules per week), a large temperature-controlled warehouse, and facilities for blister packing, bottling, and distribution. The Strathroy buildings involved in the conversion were initially constructed using a Star Building Systems metal building design and the work was carried out by Ramar Contractors. Get industry leading news, data and analysis delivered to your inbox Give your business an edge with our leading industry insights.

Original sector

Health

Location

Country

Canada

Source

Source reliability

High

Source

Pharmaceutical Technology

URL

More Details

Record type

Project

Sector

Chemical (Industrial), Commercial, Government, Manufacturing (Industrial), Metal, Oil and Gas, Warehouse

Article published date

2023-08-02

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project